BBB

R&D

Oligo therapies are emerging as promising therapeutics with the potential to address previously untreatable conditions.

News

Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in Q3, says CEO Bill Anderson.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.